# An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

> **NCT00374166** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 325 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **DRUG:** SSR149415
- **DRUG:** Placebo
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT00374166
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2016-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374166, "An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00374166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*